
Amanta Healthcare Commissions New SteriPort Facility
Amanta Healthcare Limited has announced the commissioning of its new SteriPort facility at its Kheda campus. This specialized pharmaceutical company, focusing on sterile liquids and integrated LVP/SVP manufacturing, will leverage the new facility's advanced features like absolute sterility, superior transparency, and enhanced tensile strength. The SteriPort system offers a two-port design for leak-proof IV administration and compatibility with potent drugs, particularly in Onco and Intensive Care. The brownfield expansion incorporates advanced technology and automation to reduce human interference, improve quality assurance, and enhance patient safety. The company anticipates this will lead to increased operational and financial efficiency, including EBITDA margin expansion.
Key Highlights
- New SteriPort facility commissioned at Kheda campus.
- Facility enhances container integrity and ensures leak-proof IV administration.
- Superior compatibility with potent drugs in Onco and Intensive Care.
- Aims to reduce human interference and improve patient safety.
- Expected to boost operational efficiency and EBITDA margins.
Price Impact
More from AMANTA